Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 1066 entries
Sorted by: Best Match Show Resources per page
The plausibility design, quasi-experiments and real world research: a case study of artemisinin-based combination therapy in Tanzania

quasi-experiments

[No authors listed]
GSID: vR-vIIinkKQJ
SP Kachur, PW Geissler… - Evidence, Ethos and …, 2010 - Berghan London

No abstract available.

Cite
Kachur, S. P., Geissler, P. W., & Molyneux, S. (2010). The plausibility design, quasi-experiments and real world research: a case study of artemisinin-based combination therapy in Tanzania. Evidence, Ethos and Ethnography: The Anthropology and History of Medical Research in Africa.
Kachur, S. P., P. W. Geissler, and S. Molyneux. "The plausibility design, quasi-experiments and real world research: a case study of artemisinin-based combination therapy in Tanzania." Evidence, Ethos and Ethnography: The Anthropology and History of Medical Research in Africa (2010).
Copy Download .nbib Format: MLA
Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study.

Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India

Fadeyibi IO, Ademiluyi SA, Ajose FO, Jewo PI, Akinola OI.
PMID: 22279281
Indian J Plast Surg. 2011 Sep;44(3):467-73. doi: 10.4103/0970-0358.90824.

INTRODUCTION: Idiosyncratic drug reactions (IDRs) are unexpected responses to a drug. The spectrums of severe cutaneous reactions include Stevens-Johnson Syndrome (SJS), SJS/Lyell Syndrome and Toxic Epidermal Necrolysis (TEN). The conditions are associated with high mortality. This study was designed...

Cite
Fadeyibi IO, Ademiluyi SA, Ajose FO, et al. Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study. Indian J Plast Surg. 2011;44(3):467-73doi: 10.4103/0970-0358.90824.
Fadeyibi, I. O., Ademiluyi, S. A., Ajose, F. O., Jewo, P. I., & Akinola, O. I. (2011). Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study. Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India, 44(3), 467-73. https://doi.org/10.4103/0970-0358.90824
Fadeyibi, I O, et al. "Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study." Indian journal of plastic surgery : official publication of the Association of Plastic Surgeons of India vol. 44,3 (2011): 467-73. doi: https://doi.org/10.4103/0970-0358.90824
Fadeyibi IO, Ademiluyi SA, Ajose FO, Jewo PI, Akinola OI. Severe idiosyncratic drug reactions with epidermal necrolysis: A 5-year study. Indian J Plast Surg. 2011 Sep;44(3):467-73. doi: 10.4103/0970-0358.90824. PMID: 22279281; PMCID: PMC3263276.
Copy Download .nbib Format: NLM
Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases.

Cellular & molecular immunology

Li H, Zuo J, Tang W.
PMID: 28890548
Cell Mol Immunol. 2017 Sep 11; doi: 10.1038/cmi.2017.87. Epub 2017 Sep 11.

No abstract available.

Cite
Li H, Zuo J, Tang W. Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases. Cell Mol Immunol. 2017;doi: 10.1038/cmi.2017.87.
Li, H., Zuo, J., & Tang, W. (2017). Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases. Cellular & molecular immunology, . https://doi.org/10.1038/cmi.2017.87
Li, Heng, et al. "Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases." Cellular & molecular immunology vol. (2017). doi: https://doi.org/10.1038/cmi.2017.87
Li H, Zuo J, Tang W. Water-soluble artemisinin derivatives as promising therapeutic immunosuppressants of autoimmune diseases. Cell Mol Immunol. 2017 Sep 11; doi: 10.1038/cmi.2017.87. Epub 2017 Sep 11. PMID: 28890548; PMCID: PMC5675962.
Copy Download .nbib Format: NLM
The threat of antimalarial drug resistance.

Tropical diseases, travel medicine and vaccines

Hanboonkunupakarn B, White NJ.
PMID: 28883954
Trop Dis Travel Med Vaccines. 2016 Jul 07;2:10. doi: 10.1186/s40794-016-0027-8. eCollection 2016.

The battle between man and malaria has continued for thousands of years. Antimalarial drugs are essential weapons to fight the disease, but their efficacy is threatened by drug resistance which continues to emerge creating a major obstacle to malaria...

Cite
Hanboonkunupakarn B, White NJ. The threat of antimalarial drug resistance. Trop Dis Travel Med Vaccines. 2016;2:10doi: 10.1186/s40794-016-0027-8.
Hanboonkunupakarn, B., & White, N. J. (2016). The threat of antimalarial drug resistance. Tropical diseases, travel medicine and vaccines, 210. https://doi.org/10.1186/s40794-016-0027-8
Hanboonkunupakarn, Borimas, and White, Nicholas J. "The threat of antimalarial drug resistance." Tropical diseases, travel medicine and vaccines vol. 2 (2016): 10. doi: https://doi.org/10.1186/s40794-016-0027-8
Hanboonkunupakarn B, White NJ. The threat of antimalarial drug resistance. Trop Dis Travel Med Vaccines. 2016 Jul 07;2:10. doi: 10.1186/s40794-016-0027-8. eCollection 2016. PMID: 28883954; PMCID: PMC5530994.
Copy Download .nbib Format: NLM
Early treatment failure in concurrent dengue and mixed malaria species infection with suspected resistance to artemisinin combination therapy from a tertiary care center in Delhi: a case report.

International medical case reports journal

Saksena R, Matlani M, Singh V, Kumar A, Anveshi A, Kumar D, Gaind R.
PMID: 28860870
Int Med Case Rep J. 2017 Aug 16;10:289-294. doi: 10.2147/IMCRJ.S139729. eCollection 2017.

BACKGROUND: Concurrent dengue and mixed malaria infections in a single patient present with overlapping clinical manifestations which pose a diagnostic challenge and management dilemma in areas of common endemicities.METHODS: We report a case of a young male who tested...

Cite
Saksena R, Matlani M, Singh V, et al. Early treatment failure in concurrent dengue and mixed malaria species infection with suspected resistance to artemisinin combination therapy from a tertiary care center in Delhi: a case report. Int Med Case Rep J. 2017;10:289-294doi: 10.2147/IMCRJ.S139729.
Saksena, R., Matlani, M., Singh, V., Kumar, A., Anveshi, A., Kumar, D., & Gaind, R. (2017). Early treatment failure in concurrent dengue and mixed malaria species infection with suspected resistance to artemisinin combination therapy from a tertiary care center in Delhi: a case report. International medical case reports journal, 10289-294. https://doi.org/10.2147/IMCRJ.S139729
Saksena, Rushika, et al. "Early treatment failure in concurrent dengue and mixed malaria species infection with suspected resistance to artemisinin combination therapy from a tertiary care center in Delhi: a case report." International medical case reports journal vol. 10 (2017): 289-294. doi: https://doi.org/10.2147/IMCRJ.S139729
Saksena R, Matlani M, Singh V, Kumar A, Anveshi A, Kumar D, Gaind R. Early treatment failure in concurrent dengue and mixed malaria species infection with suspected resistance to artemisinin combination therapy from a tertiary care center in Delhi: a case report. Int Med Case Rep J. 2017 Aug 16;10:289-294. doi: 10.2147/IMCRJ.S139729. eCollection 2017. PMID: 28860870; PMCID: PMC5566360.
Copy Download .nbib Format: NLM
Stable Production of the Antimalarial Drug Artemisinin in the Moss .

Frontiers in bioengineering and biotechnology

Khairul Ikram NKB, Beyraghdar Kashkooli A, Peramuna AV, van der Krol AR, Bouwmeester H, Simonsen HT.
PMID: 28861412
Front Bioeng Biotechnol. 2017 Aug 15;5:47. doi: 10.3389/fbioe.2017.00047. eCollection 2017.

Malaria is a real and constant danger to nearly half of the world's population of 7.4 billion people. In 2015, 212 million cases were reported along with 429,000 estimated deaths. The World Health Organization recommends artemisinin-based combinatorial therapies, and...

Cite
Khairul Ikram NKB, Beyraghdar Kashkooli A, Peramuna AV, et al. Stable Production of the Antimalarial Drug Artemisinin in the Moss . Front Bioeng Biotechnol. 2017;5:47doi: 10.3389/fbioe.2017.00047.
Khairul Ikram, N. K. B., Beyraghdar Kashkooli, A., Peramuna, A. V., van der Krol, A. R., Bouwmeester, H., & Simonsen, H. T. (2017). Stable Production of the Antimalarial Drug Artemisinin in the Moss . Frontiers in bioengineering and biotechnology, 547. https://doi.org/10.3389/fbioe.2017.00047
Khairul Ikram, Nur Kusaira Binti, et al. "Stable Production of the Antimalarial Drug Artemisinin in the Moss ." Frontiers in bioengineering and biotechnology vol. 5 (2017): 47. doi: https://doi.org/10.3389/fbioe.2017.00047
Khairul Ikram NKB, Beyraghdar Kashkooli A, Peramuna AV, van der Krol AR, Bouwmeester H, Simonsen HT. Stable Production of the Antimalarial Drug Artemisinin in the Moss . Front Bioeng Biotechnol. 2017 Aug 15;5:47. doi: 10.3389/fbioe.2017.00047. eCollection 2017. PMID: 28861412; PMCID: PMC5559433.
Copy Download .nbib Format: NLM
Proteomic analysis of the medicinal plant Artemisia annua: Data from leaf and trichome extracts.

Data in brief

Bryant L, Patole C, Cramer R.
PMID: 26977431
Data Brief. 2016 Feb 23;7:325-31. doi: 10.1016/j.dib.2016.02.038. eCollection 2016 Jun.

This article contains raw and processed data related to research published by Bryant et al.[1]. Data was obtained by MS-based proteomics, analysing trichome-enriched, trichome-depleted and whole leaf samples taken from the medicinal plant Artemisia annua and searching the acquired...

Cite
Bryant L, Patole C, Cramer R. Proteomic analysis of the medicinal plant Artemisia annua: Data from leaf and trichome extracts. Data Brief. 2016;7:325-31doi: 10.1016/j.dib.2016.02.038.
Bryant, L., Patole, C., & Cramer, R. (2016). Proteomic analysis of the medicinal plant Artemisia annua: Data from leaf and trichome extracts. Data in brief, 7325-31. https://doi.org/10.1016/j.dib.2016.02.038
Bryant, Laura, et al. "Proteomic analysis of the medicinal plant Artemisia annua: Data from leaf and trichome extracts." Data in brief vol. 7 (2016): 325-31. doi: https://doi.org/10.1016/j.dib.2016.02.038
Bryant L, Patole C, Cramer R. Proteomic analysis of the medicinal plant Artemisia annua: Data from leaf and trichome extracts. Data Brief. 2016 Feb 23;7:325-31. doi: 10.1016/j.dib.2016.02.038. eCollection 2016 Jun. PMID: 26977431; PMCID: PMC4781977.
Copy Download .nbib Format: NLM
A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library.

Frontiers in microbiology

Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y.
PMID: 27242757
Front Microbiol. 2016 May 23;7:743. doi: 10.3389/fmicb.2016.00743. eCollection 2016.

Although currently recommended antibiotics for Lyme disease such as doxycycline or amoxicillin cure the majority of the patients, about 10-20% of patients treated for Lyme disease may experience lingering symptoms including fatigue, pain, or joint and muscle aches. Under...

Cite
Feng J, Shi W, Zhang S, et al. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Front Microbiol. 2016;7:743doi: 10.3389/fmicb.2016.00743.
Feng, J., Shi, W., Zhang, S., Sullivan, D., Auwaerter, P. G., & Zhang, Y. (2016). A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Frontiers in microbiology, 7743. https://doi.org/10.3389/fmicb.2016.00743
Feng, Jie, et al. "A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library." Frontiers in microbiology vol. 7 (2016): 743. doi: https://doi.org/10.3389/fmicb.2016.00743
Feng J, Shi W, Zhang S, Sullivan D, Auwaerter PG, Zhang Y. A Drug Combination Screen Identifies Drugs Active against Amoxicillin-Induced Round Bodies of In Vitro Borrelia burgdorferi Persisters from an FDA Drug Library. Front Microbiol. 2016 May 23;7:743. doi: 10.3389/fmicb.2016.00743. eCollection 2016. PMID: 27242757; PMCID: PMC4876775.
Copy Download .nbib Format: NLM
Treatment-seeking Paths in the Management of Severe Malaria in Children under 15 Years of Age Treated in Reference Hospitals of Kinshasa, Democratic Republic of Congo.

Tropical medicine and health

Ilunga-Ilunga F, Levêque A, Ngongo LO, Laokri S, Dramaix M.
PMID: 25729313
Trop Med Health. 2015 Mar;43(1):11-9. doi: 10.2149/tmh.2014-19. Epub 2014 Oct 16.

BACKGROUND: In the Democratic Republic of Congo (DRC), few studies have focused on treatment-seeking paths selected by caretakers for the management of severe childhood malaria in an urban environment. The present study aims at describing the treatment-seeking paths according...

Cite
Ilunga-Ilunga F, Levêque A, Ngongo LO, et al. Treatment-seeking Paths in the Management of Severe Malaria in Children under 15 Years of Age Treated in Reference Hospitals of Kinshasa, Democratic Republic of Congo. Trop Med Health. 2014;43(1):11-9doi: 10.2149/tmh.2014-19.
Ilunga-Ilunga, F., Levêque, A., Ngongo, L. O., Laokri, S., & Dramaix, M. (2015). Treatment-seeking Paths in the Management of Severe Malaria in Children under 15 Years of Age Treated in Reference Hospitals of Kinshasa, Democratic Republic of Congo. Tropical medicine and health, 43(1), 11-9. https://doi.org/10.2149/tmh.2014-19
Ilunga-Ilunga, Félicien, et al. "Treatment-seeking Paths in the Management of Severe Malaria in Children under 15 Years of Age Treated in Reference Hospitals of Kinshasa, Democratic Republic of Congo." Tropical medicine and health vol. 43,1 (2015): 11-9. doi: https://doi.org/10.2149/tmh.2014-19
Ilunga-Ilunga F, Levêque A, Ngongo LO, Laokri S, Dramaix M. Treatment-seeking Paths in the Management of Severe Malaria in Children under 15 Years of Age Treated in Reference Hospitals of Kinshasa, Democratic Republic of Congo. Trop Med Health. 2015 Mar;43(1):11-9. doi: 10.2149/tmh.2014-19. Epub 2014 Oct 16. PMID: 25729313; PMCID: PMC4317488.
Copy Download .nbib Format: NLM
Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy.

Oncology letters

Zhang ZS, Wang J, Shen YB, Guo CC, Sai KE, Chen FR, Mei X, Han FU, Chen ZP.
PMID: 26171034
Oncol Lett. 2015 Jul;10(1):379-383. doi: 10.3892/ol.2015.3183. Epub 2015 May 06.

Artemisinin, a powerful antimalarial medicine, is extracted from the Chinese herb,

Cite
Zhang ZS, Wang J, Shen YB, et al. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncol Lett. 2015;10(1):379-383doi: 10.3892/ol.2015.3183.
Zhang, Z. S., Wang, J., Shen, Y. B., Guo, C. C., Sai, K. E., Chen, F. R., Mei, X., Han, F. U., & Chen, Z. P. (2015). Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncology letters, 10(1), 379-383. https://doi.org/10.3892/ol.2015.3183
Zhang, Ze-Shun, et al. "Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy." Oncology letters vol. 10,1 (2015): 379-383. doi: https://doi.org/10.3892/ol.2015.3183
Zhang ZS, Wang J, Shen YB, Guo CC, Sai KE, Chen FR, Mei X, Han FU, Chen ZP. Dihydroartemisinin increases temozolomide efficacy in glioma cells by inducing autophagy. Oncol Lett. 2015 Jul;10(1):379-383. doi: 10.3892/ol.2015.3183. Epub 2015 May 06. PMID: 26171034; PMCID: PMC4487108.
Copy Download .nbib Format: NLM
The availability of six tracer medicines in private medicine outlets in Uganda.

Journal of pharmaceutical policy and practice

Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, Pollock A.
PMID: 25667747
J Pharm Policy Pract. 2014 Dec 08;7(1):18. doi: 10.1186/s40545-014-0018-y. eCollection 2014.

OBJECTIVES: Many low income countries struggle to provide safe and effective medicines due to poor public health care infrastructure, budgetary constraints, and lack of human resource capacity. Private sector pharmacies and drug shops are used by a majority of...

Cite
Birabwa C, Murison J, Evans V, et al. The availability of six tracer medicines in private medicine outlets in Uganda. J Pharm Policy Pract. 2014;7(1):18doi: 10.1186/s40545-014-0018-y.
Birabwa, C., Murison, J., Evans, V., Obua, C., Agaba, A., Waako, P., & Pollock, A. (2014). The availability of six tracer medicines in private medicine outlets in Uganda. Journal of pharmaceutical policy and practice, 7(1), 18. https://doi.org/10.1186/s40545-014-0018-y
Birabwa, Catherine, et al. "The availability of six tracer medicines in private medicine outlets in Uganda." Journal of pharmaceutical policy and practice vol. 7,1 (2014): 18. doi: https://doi.org/10.1186/s40545-014-0018-y
Birabwa C, Murison J, Evans V, Obua C, Agaba A, Waako P, Pollock A. The availability of six tracer medicines in private medicine outlets in Uganda. J Pharm Policy Pract. 2014 Dec 08;7(1):18. doi: 10.1186/s40545-014-0018-y. eCollection 2014. PMID: 25667747; PMCID: PMC4276013.
Copy Download .nbib Format: NLM
Two distinct and competitive pathways confer the cellcidal actions of artemisinins.

Microbial cell (Graz, Austria)

Sun C, Li J, Cao Y, Long G, Zhou B.
PMID: 28357259
Microb Cell. 2015 Jan 02;2(1):14-25. doi: 10.15698/mic2015.01.181.

The biological actions of artemisinin (ART), an antimalarial drug derived from

Cite
Sun C, Li J, Cao Y, et al. Two distinct and competitive pathways confer the cellcidal actions of artemisinins. Microb Cell. 2015;2(1):14-25doi: 10.15698/mic2015.01.181.
Sun, C., Li, J., Cao, Y., Long, G., & Zhou, B. (2015). Two distinct and competitive pathways confer the cellcidal actions of artemisinins. Microbial cell (Graz, Austria), 2(1), 14-25. https://doi.org/10.15698/mic2015.01.181
Sun, Chen, et al. "Two distinct and competitive pathways confer the cellcidal actions of artemisinins." Microbial cell (Graz, Austria) vol. 2,1 (2015): 14-25. doi: https://doi.org/10.15698/mic2015.01.181
Sun C, Li J, Cao Y, Long G, Zhou B. Two distinct and competitive pathways confer the cellcidal actions of artemisinins. Microb Cell. 2015 Jan 02;2(1):14-25. doi: 10.15698/mic2015.01.181. PMID: 28357259; PMCID: PMC5361647.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 1066 entries